Original Investigation

Amoxicillin-Clavulanate vs Amoxicillin for Acute Sinusitis in Adults

JAMA 10.1001/jama.2025.26902

April 18, 2026 at 7:30 AM EDT

Read the full article

For acute sinusitis in adults younger than 65 years, is standard-dose amoxicillin-clavulanate associated with different risks of treatment failure and adverse events compared with standard-dose amoxicillin?In this retrospective cohort study of 521 244 adults with acute sinusitis, overall treatment failure was rare (3.1%). There was no observed difference in treatment failure between treatment groups and an elevated relative risk, corresponding to a small absolute increase in risk, of yeast infections and infections among patients treated with amoxicillin-clavulanate.These findings support standard-dose amoxicillin as a preferred empiric choice for adults younger than 65 years with uncomplicated acute sinusitis for whom an antibiotic is indicated.

Corresponding Author: Timothy J. Savage, MD, MPH, MSc, Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital, 1620 Tremont St, Ste 3030, Boston, MA 02120 (tsavage@mgb.org).

Link to the article in your story

We encourage you to link out to this article in your story using the link below. It includes an access token that will give free access to the article for your readers up to one year after publication. (The link will be live after the article publishes and embargo is lifted.)

Please see the article for additional information, including full author list, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

Need more information? Contact us.

Editor's Picks